NEW YORK, Nov. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This report analyzes the worldwide markets for Apoptosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 114 companies including many key and niche players such as Abbott Laboratories, AbGenomics International, Inc., Aegera Therapeutics, Inc., Amgen, Inc., Anavex Life Sciences Corporation, ApopLogic Pharmaceuticals Inc., Ascenta Therapeutics, ArQule, Inc., Bioniche Life Sciences, Inc., Celgene Corporation, Chroma Therapeutics Ltd., Cancer Research Technology Ltd., EntreMed, Inc., EpiCept Corporation, Exelixis Inc., Genextra S.p.A, Genta, Inc., Infinity Pharmaceuticals Inc., ISIS Pharmaceutical Inc., Novartis Ltd., Pfizer, Inc., Pharmacyclics, Inc., S*BIO Pte Ltd., S*BIO Pte Ltd, TopoTarget A/S, Xigen SA, and AEterna Zentaris GmbH. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3<
Copyright©2010 PR Newswire.
All rights reserved